ARCHIVES

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 09 | March 1, 1985

Download PDF Visit The Full Archive

Related Articles

Public Forum On NRSA Tuition Policies

April 14, 1995

Spotlight Article TCL Archive

Breast Cancer Report To The Profession Suddenly Is a Report To The Nation; Treatment Progress Noted

October 4, 1974

In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship

December 11, 1992

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

February 29, 2008

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

Kington Named Acting NIH Director.

November 14, 2008